Eledon Pharmaceuticals, Inc.·4

Jan 16, 5:00 PM ET

Lee June 4

4 · Eledon Pharmaceuticals, Inc. · Filed Jan 16, 2026

Insider Transaction Report

Form 4
Period: 2026-01-10
Lee June
Director
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-10+3,4303,430 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1]
    2026-01-103,4300 total
    Common Stock (3,430 underlying)
Footnotes (1)
  • [F1]Represents shares issuable on settlement of restricted stock units ("RSUs") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026.
Signature
/s/ Paul Little, as attorney-in-fact for June Lee|2026-01-16

Documents

1 file
  • 4
    ownership.xmlPrimary

    4